Genialis

United States
Panora, Iowa, United States

Company profile

Genialis company profile

Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform. It engages in unraveling complex biology to find new ways to address disease. Its platform defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development. Genialis was established in 2015 in Boston, Massachusetts by Rafael Rosengarten.

Business identity

Contact email
[email protected]
Phone number
+1 617 237 0085
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2015-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$15.3M
Last funding
Series A / $13M / 2023-03-29
Last equity funding
Series A / $13M
Investors
9
Lead investors
5
Founders
6
Articles
38

Founders and investors

Founders

Cedric OdjeKlemen HrovatLuka AusecMiha StajdoharNejc SkoberneRafael Rosengarten

Lead investors

Debiopharm Innovation FundEISMEAFirst Star VenturesredalpineTaiwania Capital Management Corporation

Investors

EISMEAFirst Star VenturesredalpineScaleX VenturesTaiwania Capital Management Corporation